Concepedia

Zhizhou Fang

ZF

Statistics

Publications

8

Citations

284

H-Index

8

Active since

2013

Affiliations

TU Dortmund University(Current)

Merck KGaA, Darmstadt (Germany)

Max Planck Institute of Molecular Physiology

German Cancer Research Center

Stellenbosch University

Zhizhou Fang is an author at TU Dortmund University specializing in drug discovery, drug design, and pharmacy.

ORCID

Publications per year

2013–2025

8

Publications

8

Covalent‐Allosteric Kinase Inhibitors

Jörn Weisner, Rajesh Gontla, Leandi Van Der Westhuizen et al. · Angewandte Chemie International Edition · 2015 · 113 citations

, , +17

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma

Johannes Brägelmann, Marcel A. Dammert, Felix Dietlein et al. · Cell Reports · 2017 · 55 citations · Full text

, , +17

Discovery of Inter-Domain Stabilizers—A Novel Assay System for Allosteric Akt Inhibitors

Zhizhou Fang, Jeffrey R. Simard, Dennis Plenker et al. · ACS Chemical Biology · 2014 · 25 citations · Full text

, , +14

Overcoming Compound Fluorescence in the FLiK Screening Assay with Red-Shifted Fluorophores

R. Schneider, Anne Gohla, Jeffrey R. Simard et al. · Journal of the American Chemical Society · 2013 · 24 citations

, , +16

Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening

Dong Ye, Anna Harder, Zhizhou Fang et al. · Pharmaceutical Research · 2020 · 21 citations

, , +8

1–5 of 8